Powder Delivery TRIZ Cases

Hydrophobic cabotegravir prodrugs encapsulated in poloxamer-stabilized nanoparticles enable sustained drug release.

A semisolid mucoadhesive formulation combines polyacrylic acid with acrylic acid polymers to enhance bioadhesion and controlled drug release.

Supercritical carbon dioxide prevents particle agglomeration during coating, enabling precise osmotic and thermal release of active agents.

Applying shear stress creates amorphous nano-molecular aggregates, resolving low aqueous solubility and hydrophobic membrane permeability challenges.

Inhaled argon gas composition modulates microglial activity to protect the brain from neurological damage.

Covalent coupling of hydrophobic drugs to squalenic derivatives creates stable nanoparticles that eliminate toxic surfactants and improve bioavailability.

Block copolymers with sub-1 kDa PEG segments maintain nanoparticle stability in biological media while preserving high transfection efficiency.

Cyclodextrin inclusion complexes stabilize high-concentration TLR agonists, resolving formulation instability for cancer therapies.

Composite hydrogel microspheres expand dynamically to provide reliable tissue bulking in severe degeneration cases.

A Morchella-based pharmaceutical composition increases testosterone concentration and reduces reactive oxygen species in sperm cells.

Ethyl acetate and n-hexane replace toxic chloroform while trehalose protects bilayer structure during lyophilization.

Segmented biphasic excipients partition hydrophobic agents into epithelium, bypassing hepatic metabolism and reducing excretion.

PD-L1 targeting peptides on extracellular vesicles deliver MIR503HG RNA to reverse cellular senescence and reduce off-target effects.

Segmented pellet formulation delivers once-nightly dosing with bioavailability matching twice-nightly immediate release solutions.

A dual solvent system controls sequential precipitation to resolve drug-polymer mismatch, achieving high loading efficiency.

Chiral nanozymes overcome low substrate selectivity by maximizing enzymatic activity under circularly polarized light to reduce glucose levels in cancer cells.

Segmented release mechanisms improve bioavailability while reducing sodium intake, enabling convenient once-nightly dosing for narcolepsy treatment.

Phospholipid-mediated mixed micelles dissolve curcumin co-crystals, eliminating organic solvent residues while boosting bioavailability.

Seven amino acid composition increases glomerular filtration rate to halt chronic kidney disease progression.

Cyclic thioester macromonomers enable catalyst-free native chemical ligation to form stable hydrogels without generating toxic by-products.

Biochar pellets use nanocrystalline cellulose and bentonite binders to form dense, non-dusty structures.

Low atomic-number particles create unique 80:140 kVp ratios to differentiate from iodine and barium agents, resolving diagnostic ambiguity.

A polyribonucleotide-protein complex self-assembles into nanoparticles to enhance intracellular delivery of CRISPR components.

A dual-agonist GLP-1 and GIP receptor composition stabilizes the active polypeptide through optimized buffer and osmoregulator excipients.

A nanoparticle system blends pH-sensitive and insensitive polymers to protect payload molecules during transit.

Composite matrix balances biosorbability with suture retention, preventing CSF leakage during dural repair.

Reducing particle size to nanoscale improves water solubility and therapeutic potency while preventing gastrointestinal degradation.

Zinc oxide nanoparticles shield RNA from thermal degradation and nuclease attack, enabling stable storage without cold chain infrastructure.

A chitosan-polyethylene glycol interpolymer transitions from liquid to gel at body temperature to enable controlled therapeutic agent release.

Antibody-conjugated nanoparticles generate photoacoustic signals to visualize tumors as small as 2 mm in diameter.

Double nanoencapsulated mRNA vaccine maintains room temperature stability without polyethylene glycol.

Flavonoid derivatives mask the bitter taste of micronized indomethacin, enabling rapid absorption in effervescent preparations.

Specific leucine to trileucine weight ratios adjust compressed bulk density, resolving payload stability trade-offs in dry powder inhalation.

Combining TURSO with sodium phenylbutyrate reduces tau levels and inflammatory markers in neurodegenerative disease treatment.

Amphipathic peptide nanostructures mimic natural high-density lipoprotein to modulate cellular cholesterol influx and efflux.

Probiotic fermentation converts raw herbs into a convenient, palatable preparation that improves drug absorption and reduces oxidative stress.

Organic anions with pKa 0.5 to 3.5 protect asparaginyl residues from degradation, enabling stable ready-to-use aqueous formulations.

Angiopeptide composition delivers growth factors to ischemic tissues, overcoming short protein half-life and enhancing therapeutic efficacy.

Optimizing nanoparticle size to 1-10 nm resolves the trade-off between blood circulation half-life and renal clearance, reducing liver accumulation.

Modified polysaccharide matrices and polyoxyethylene sorbitan monofatty acid esters prevent spray drying stickiness while maintaining beverage clarity.

Metal oxide nanoparticles doped with rare earth elements generate reactive oxygen species under radiation to treat cancer cells.

A multi-extract herbal composition treats psoriasis by promoting immune balance and improving skin symptoms.

A Candida adhesin vaccine induces specific immune responses against fungal pathogens.

Amorphous dispersion in fusible polymeric carrier maintains stability at 40°C and 75% humidity while improving bioavailability.

Magnetic nano-ligands slide on substrates to reversibly control stem cell adhesion, overcoming static presentation limits.

Composite cannabinoid formulation with emulsifiers addresses ineffective dementia treatments by enhancing bioavailability to slow disease progression.

Gadolinium-chelated polysiloxane nanoparticles provide sustained tumor contrast and radiosensitization during magnetic resonance image-guided radiation therapy.

Lyophilized Justicia plant extract retains hemoglobin content to address human blood shortages and storage limitations.